Revankar Shriram
SEC CIK 1928994 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DLB | Dolby Laboratories, Inc. | SVP, Advanced Technology Group | 73.3K | — | $1.27M | 18 | 2022-05-16 | 2026-08-14 |
Most active insiders at DLB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | YEAMAN KEVIN J | Pres, CEO, Dir | — | $8.72M |
| 2 | Couling John D | SVP, Entertainment | — | $3.82M |
| 3 | SHERMAN MARK ANDREW | EVP, Gen. Counsel, Sec | — | $1.08M |
| 4 | Revankar Shriram | SVP, Advanced Technology Group | — | $747.9K |
| 5 | Pendleton Todd | SVP, CMO | — | $647.9K |
| 6 | Nicholson Ryan | VP, CAO, Corp. Ctrl | — | $359.5K |
| 7 | Park Robert J | SVP, CFO | — | $277.4K |
| 8 | Prophet Tony A | Dir | — | $223.9K |
| 9 | Rollins Emily | Dir | — | $60.1K |
| 10 | Whitten Marc | Pres, CEO, Dir | — | — |
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-08-18 17:14 | 2026-08-14 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | S - Sale | $62.71 | -3,000 | 73.3K | -4% | -$188.1K |
| T | 2026-05-19 17:31 | 2026-05-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | S - Sale | $54.90 | -3,000 | 80.6K | -4% | -$164.7K |
| T | 2026-05-19 17:31 | 2026-05-18 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $54.21 | -4,329 | 76.3K | -5% | -$234.7K |
| T | 2026-02-17 | 2026-02-17 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | S - Sale | $66.14 | -3,000 | 83.2K | -3% | -$198.4K |
| DM | 2025-12-17 | 2025-12-15+ | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $67.25 | -7,246 | 88.5K | -8% | -$487.3K |
| D | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | M - OptEx | $0.00 | +3,412 | 93.5K | +4% | $0 |
| D | 2025-12-17 | 2025-12-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | A - Grant | $0.00 | +22.6K | 90.1K | +34% | $0 |
| T | 2025-11-24 | 2025-11-21 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | S - Sale | $65.55 | -3,000 | 67.4K | -4% | -$196.7K |
| 2025-08-26 | 2025-08-22 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | S - Sale | $74.92 | -7,000 | 70.4K | -9% | -$524.4K | |
| 2025-05-20 | 2025-05-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $77.24 | -4,329 | 77.4K | -5% | -$334.4K | |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $79.18 | -3,364 | 81.4K | -4% | -$266.4K |
| D | 2024-12-18 | 2024-12-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | A - Grant | $0.00 | +18.1K | 84.8K | +27% | $0 |
| 2024-05-17 | 2024-05-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $83.70 | -4,409 | 66.6K | -6% | -$369.0K | |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | A - Grant | $0.00 | +16.1K | 72.1K | +29% | $0 |
| D | 2023-12-19 | 2023-12-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $88.60 | -1,309 | 70.8K | -2% | -$116.0K |
| 2023-05-18 | 2023-05-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | F - Tax | $84.32 | -4,285 | 55.6K | -7% | -$361.3K | |
| D | 2022-12-16 | 2022-12-15 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | A - Grant | $0.00 | +10.6K | 59.5K | +22% | $0 |
| D | 2022-05-17 | 2022-05-16 | DLB | Dolby Laboratories, Inc. | Revankar Shriram | SVP, Advanced Technology Group | A - Grant | $0.00 | +48.9K | 48.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations